Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Barletta Giulia

Ricercatore sanitario; MD

Ospedale Policlinico San Martino

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Articles (14)

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (10)

Marco Tagliamento

Researcher/Assistant Professor

University of Genoa

ITALY

View details

Silvia Marconi

Researcher

University of Brescia

ITALY

View details

Sara Santamaria

Ricercatore sanitario

Ospedale Policlinico San Martino

ITALY

View details

Angela Alama

Senior Staff Scientist

IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro

ITALY

View details

Roberta Tasso

Associate Professor

University of Genova

ITALY

View details

Giovanna Chiorino

Head/Ph.D.

Fondazione Edo ed Elvo Tempia

ITALY

View details

Bailey Fitzgerald

Roswell Park Comprehensive Cancer Center

UNITED STATES

View details

Amin Nassar

Yale University

UNITED STATES

View details

Lorenzo Antonuzzo

University of Florence

ITALY

View details

Paul Rubinstein

Attending Physician/Visiting Associate Professor

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Barletta Giulia

Research Interests

Explore related searches

Articles (14)

APOLLO11: a bio-data-driven model for clinical and translational research in lung cancer

Outcomes of first-line chemo-immunotherapy in advanced non-squamous NSCLC according to KRAS status: An Italian real-world study

Real-world description of patients with resected epidermal growth factor receptor mutation positive non-small cell lung carcinoma treated with adjuvant osimertinib in an early access program in Italy: the ELBA observational study

Immune Checkpoint Inhibitors and Targeted Therapies in Early-Stage Non-Small-Cell Lung Cancer: State-of-the-Art and Future Perspectives

Extracellular vesicles miR-574-5p and miR-181a-5p as prognostic markers in NSCLC patients treated with nivolumab.

Activity of osimeRTInib in non-small-cell lung Cancer with UNcommon epidermal growth factor receptor mutations: retrospective Observational multicenter study (ARTICUNO)

Circulating Osteopontin Predicts Clinical and Radiological Response in First-Line Treatment of Advanced Non-Small Cell Lung Cancer

Front-line liquid biopsy for early molecular assessment and treatment of hospitalized lung cancer patients

Improved overall survival in patients developing endocrine toxicity during treatment with nivolumab for advanced non-small cell lung cancer in a prospective study

Molecular and Genetic Advances in Small Cell Lung Cancer Landscape: From Homogeneity to Diversity

Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium

Prognostic Role of Soluble and Extracellular Vesicle-Associated PD-L1, B7-H3 and B7-H4 in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors

Diagnosis of lung cancer following emergency admission: Examining care pathways, clinical outcomes, and advanced NSCLC treatment in an Italian cancer Center

Neuromuscular and cardiac adverse events associated with immune checkpoint inhibitors: pooled analysis of individual cases from multiple institutions and literature

Collaborators (10)

Marco Tagliamento

Silvia Marconi

Sara Santamaria

Angela Alama

Roberta Tasso

Giovanna Chiorino

Bailey Fitzgerald

Amin Nassar

Lorenzo Antonuzzo

Paul Rubinstein

Make your next move.